Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04949568 · ClinicalTrials.gov registry record · NA

Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes

A NA study of Diabetes Mellitus, Type 2 and Patient Engagement, sponsored by New York University.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04949568 is a NA study of Diabetes Mellitus, Type 2 and Patient Engagement that is active but no longer recruiting, run by New York University. The registered enrollment target is 40 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04949568, a NA study of Diabetes Mellitus, Type 2 and Patient Engagement, is active but no longer recruiting, sponsored by New York University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The objective of the study is to conduct a pilot randomized study to test feasibility and preliminary efficacy of the developed diabetes self-management education program with 40 adult Haitian immigrants.

Interventions

  • BEHAVIORAL Diabetes Self-Management Behaviors

Study Locations (1)

New York

  • New York University - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-08-12
Est. Completion 2025-12-31
Phase NA

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT04949568

The ClinicalTrials.gov registry entry for NCT04949568 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Self-Management Behaviors is the first listed.

NCT04949568 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04949568 about?

NCT04949568 is a clinical study titled "Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes". The objective of the study is to conduct a pilot randomized study to test feasibility and preliminary efficacy of the developed diabetes self-management education program with 40 adult Haitian immigrants.

What is the current status of trial NCT04949568?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-12. Estimated completion is 2025-12-31.

What conditions does trial NCT04949568 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Patient Engagement, Patient Education.

What interventions are being tested in trial NCT04949568?

The interventions under investigation include: Diabetes Self-Management Behaviors (BEHAVIORAL).

Who is sponsoring clinical trial NCT04949568?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04949568 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.